Pharmacotherapeutic advances in fibromyalgia: what's new on the horizon?

Sarzi-Puttini P, Giorgi V, Sirotti S, Bazzichi L, Lucini D, Di Lascio S, Pellegrino G, Fornasari D.
Pharmacotherapeutic advances in fibromyalgia: what's new on the horizon?
Expert Opin Pharmacother. 2024 Jun 12:1-19. doi: 10.1080/14656566.2024.2365326. Epub ahead of print. PMID: 38853631

Introduction: This review delves into Fibromyalgia Syndrome (FMS), a chronic pain condition demanding thorough understanding for precise diagnosis and treatment. Yet, a definitive pharmacological solution for FMS remains elusive.

Areas covered: In this article, we systematically analyze various pharmacotherapeutic prospects for FMS treatment, organized into sections based on the stage of drug development and approval. We begin with an overview of FDA-approved drugs, discussing their efficacy in FMS treatment. Next, we delve into other medications currently used for FMS but still undergoing further study, including opioids and muscle relaxants. Further, we evaluate the evidence behind medications that are currently under study, such as cannabinoids and naltrexone. Lastly, we explore new drugs that are in phase II trials. Our research involved a thorough search on PUBMED, Google Scholar, and We also discuss the action mechanisms of these drugs and their potential use in specific patient groups.

Expert opinion: A focus on symptom-driven, combination therapy is crucial in managing FMS. There is also a need for ongoing research into drugs that target neuroinflammation, immunomodulation, and the endocannabinoid system. Bridging the gap between benchside research and clinical application is challenging, but it holds potential for more targeted and effective treatment strategies.

Associazione Italiana per lo Studio del Dolore ETS
Sede legale: Via Tacito 7 - 00193 Roma
Codice Fiscale 80027230483 -  P.IVA: 14600111000

Articoli, notizie, comunicati possono essere inviati a:

Per informazioni riguardanti le iscrizioni:


L'Associazione Italiana per lo Studio del Dolore è il capitolo italiano dell'International Association for the Study of Pain IASP® e della European Pain Federation EFIC®